Showing results (151-160 of 169) with videos related to
Sort By:
Pageof 17
Anticancer Research|April 1, 2009
Neoadjuvant weekly paclitaxel with and without trastuzumab in locally advanced or metastatic breast cancerJun Horiguchi, Tetsunari Oyama, Yukio Koibuchi, et al.Molecular and Clinical Oncology|March 21, 2014
Postrecurrence survival of surgically resected pulmonary adenocarcinoma patients according to EGFR and KRAS mutation statusYoichi Ohtaki, Kimihiro Shimizu, Seiichi Kakegawa, et al.The Journal of Clinical Endocrinology and Metabolism|January 27, 2012
Expression and mutations of KCNJ5 mRNA in Japanese patients with aldosterone-producing adenomasRyo Taguchi, Masanobu Yamada, Yasuyo Nakajima, et al.The Journal of Molecular Diagnostics : JMD|December 17, 2009
Usefulness of peptide nucleic acid (PNA)-clamp smart amplification process version 2 (SmartAmp2) for clinical diagnosis of KRAS codon 12 mutations in lung adenocarcinoma: comparison of PNA-clamp SmartAmp2 and PCR-related methodsTakuya Araki, Kimihiro Shimizu, Katsunori Nakamura, et al.Surgical Laparoscopy, Endoscopy & Percutaneous Techniques|December 3, 2014
Modified Pringle Maneuver Applicable for Laparoscopic HepatectomyYutaka Sunose, Keitaro Hirai, Seshiru Nakazawa, et al.Surgical Laparoscopy, Endoscopy & Percutaneous Techniques|June 4, 2015
Securing the surgical field in laparoscopic pancreatectomy using a Penrose drain and Endo CloseYutaka Sunose, Keitaro Hirai, Seshiru Nakazawa, et al.Anticancer Research|May 4, 2005
A combination phase I study of weekly paclitaxel and doxifluridine in advanced gastric cancer patientsIzumi Takeyoshi, Fujio Makita, Yoshifumi Tanahashi, et al.Journal of Global Oncology|July 19, 2017
Impact of the Bim Deletion Polymorphism on Survival Among Patients With Completely Resected Non-Small-Cell Lung CarcinomaJun Atsumi, Kimihiro Shimizu, Yoichi Ohtaki, et al.Cancer Medicine|May 27, 2016
Prognostic potential of the MDM2 309T>G polymorphism in stage I lung adenocarcinomaYasuaki Enokida, Kimihiro Shimizu, Jun Atsumi, et al.Circulation|January 12, 2005
KRP-203, a novel synthetic immunosuppressant, prolongs graft survival and attenuates chronic rejection in rat skin and heart allograftsHisashi Shimizu, Masafumi Takahashi, Takashi Kaneko, et al.Pageof 17